Literature DB >> 9524082

Incidence studies of primary and secondary intracranial tumors: a systematic review of their methodology and results.

C E Counsell1, R Grant.   

Abstract

We reviewed the incidence studies of intracranial tumors to compare their methodology and identify whether there was evidence of true differences in incidence by time, place, age, or sex. Studies were identified from Medline (1966-95), bibliographies of relevant articles, and personal knowledge. For each study, various methodological details were recorded, along with the age-standardized incidence of all primary tumors and the crude and age/sex-specific incidences of different types of intracranial tumor. Methodological factors which significantly influenced the reported incidence were identified and the results of different studies were compared and combined in a meta-analysis if appropriate. Twenty studies (over 20,000 primary tumors) were included. Higher incidences of primary tumors were found in studies that: used many methods to identify cases (odds ratio [OR] 1.92); included a high percentage of asymptomatic patients (OR 2.03); did not require histologic confirmation of the diagnosis (OR 1.69). Studies from the 1980's reported higher incidences than in previous decades (OR 1.51), probably because of improved methodology. Comparable studies from the 1980's gave widely different incidence rates for all primary tumors (7.1-18.6 per 100,000 per year). In all studies, the incidence of neuroepithelial and meningeal tumors increased dramatically with age. Neuroepithelial tumors were 40% more common in men, whilst meningeal and cranial nerve tumors were about 80% and 40% more common in women, respectively. Further incidence studies are required to establish geographical and secular variations in the incidence of primary intracranial tumors but these must use comparable methodologies. Provisional guidelines for future studies are given.

Entities:  

Mesh:

Year:  1998        PMID: 9524082     DOI: 10.1023/a:1005861024679

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Some epidemiologic aspects of neoplastic diseases in Israeli immigrant population. 3. Brain tumors.

Authors:  A Cohen; B Modan
Journal:  Cancer       Date:  1968-12       Impact factor: 6.860

2.  Descriptive epidemiology of malignant brain tumors in the Swiss Canton of Vaud.

Authors:  F Levi; C La Vecchia; V C Te
Journal:  Neuroepidemiology       Date:  1990       Impact factor: 3.282

3.  Epidemiologic study of primary intracranial neoplasms.

Authors:  J F Annegers; B S Schoenberg; H Okazaki; L T Kurland
Journal:  Arch Neurol       Date:  1981-04

4.  Neoplasms of the central nervous system in Norway. III. Epidemiological characteristics of intracranial gliomas according to histology.

Authors:  A Helseth; S J Mørk
Journal:  APMIS       Date:  1989-06       Impact factor: 3.205

5.  An epidemiological survey of primary tumours of the brain and spinal cord in South East Wales.

Authors:  G C Cole; P R Wilkins; R R West
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

6.  The descriptive epidemiology of primary intracranial neoplasms: the Connecticut experience.

Authors:  B S Schoenberg; B W Christine; J P Whisnant
Journal:  Am J Epidemiol       Date:  1976-11       Impact factor: 4.897

7.  Incidence of primary intracranial neoplasms in an isolated population (the Faroese) during the period 1962-1975.

Authors:  P Joensen
Journal:  Acta Neurol Scand       Date:  1981-07       Impact factor: 3.209

8.  Primary brain tumor incidence rates in four United States regions, 1985-1989: a pilot study.

Authors:  F G Davis; N Malinski; W Haenszel; J Chang; J Flannery; S Gershman; R Dibble; D D Bigner
Journal:  Neuroepidemiology       Date:  1996       Impact factor: 3.282

9.  Neoplasms of the central nervous system in Norway. IV. A population-based epidemiological study of meningiomas.

Authors:  A Helseth; S J Mørk; A Johansen; S Tretli
Journal:  APMIS       Date:  1989-07       Impact factor: 3.205

10.  Epidemiology of primary intracranial neoplasms in Manitoba, Canada.

Authors:  G R Sutherland; R Florell; D Louw; N W Choi; A A Sima
Journal:  Can J Neurol Sci       Date:  1987-11       Impact factor: 2.104

View more
  16 in total

1.  Overview: Brain tumour diagnosis and management/Royal College of Physicians guidelines.

Authors:  R Grant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 2.  Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases.

Authors:  M G Hart; R Grant; M Walker; H Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

3.  Incidence of brain tumours in two English counties: a population based study.

Authors:  L H Pobereskin; J B Chadduck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

4.  Should GPs have direct access to neuroradiological investigation when adults present with headache?

Authors:  David Kernick; Stuart Williams
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

Review 5.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

6.  French brain tumor data bank: methodology and first results on 10,000 cases.

Authors:  Luc Bauchet; Valérie Rigau; Hélène Mathieu-Daudé; Dominique Figarella-Branger; Delphine Hugues; Loreleï Palusseau; Fabienne Bauchet; Michel Fabbro; Chantal Campello; Laurent Capelle; Anne Durand; Brigitte Trétarre; Didier Frappaz; Dominique Henin; Philippe Menei; Jérome Honnorat; François Segnarbieux
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.130

7.  Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

Authors:  Sumia Ali; Gwendalyn D King; James F Curtin; Marianela Candolfi; Weidong Xiong; Chunyan Liu; Mariana Puntel; Queng Cheng; Jesus Prieto; Antoni Ribas; Jerzy Kupiec-Weglinski; Nico van Rooijen; Hans Lassmann; Pedro R Lowenstein; Maria G Castro
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

8.  Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab.

Authors:  Jidong Hong; Yuping Peng; Yuping Liao; Wuzhong Jiang; Rui Wei; Lei Huo; Zaide Han; Chaojun Duan; Meizuo Zhong
Journal:  Exp Ther Med       Date:  2012-04-19       Impact factor: 2.447

9.  Imaging patients with suspected brain tumour: guidance for primary care.

Authors:  David P Kernick; Fayyaz Ahmed; Anish Bahra; Andrew Dowson; Giles Elrington; Manuela Fontebasso; Nicola J Giffin; Sue Lipscombe; Anne MacGregor; Richard Peatfield; Stuart Weatherby; Tom Whitmarsh; Peter J Goadsby
Journal:  Br J Gen Pract       Date:  2008-12       Impact factor: 5.386

10.  Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma.

Authors:  Ersoy Oksuz; Fatmahan Atalar; Gamze Tanırverdi; Ayahan Bilir; Andleeb Shahzadi; Zeliha Yazici
Journal:  J Neurooncol       Date:  2015-10-27       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.